NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 25 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,128 | +2.1% | 500,000 | 0.0% | 0.01% | +18.2% |
| Q2 2023 | $462,430 | -1.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $470,000 | +2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $458,750 | -3.0% | 500,000 | 0.0% | 0.01% | -8.3% |
| Q3 2022 | $473,000 | +1.5% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $466,000 | -13.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $541,000 | -2.7% | 500,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $556,000 | -17.6% | 500,000 | 0.0% | 0.01% | -7.1% |
| Q3 2021 | $675,000 | -22.1% | 500,000 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $866,000 | +12.3% | 500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $771,000 | -15.5% | 500,000 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $912,000 | +17.7% | 500,000 | 0.0% | 0.02% | -5.0% |
| Q3 2020 | $775,000 | +13.5% | 500,000 | 0.0% | 0.02% | +5.3% |
| Q2 2020 | $683,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $65,368,000 | 1.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 50,366,000 | $53,863,000 | 0.53% |
| DeepCurrents Investment Group LLC | 12,930,000 | $13,857,000 | 0.43% |
| Aequim Alternative Investments LP | 7,300,000 | $7,891,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,290,000 | $5,656,000 | 0.09% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,167,000 | $32,611,000 | 0.09% |
| Verition Fund Management LLC | 3,823,000 | $4,133,000 | 0.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,534,000 | $1,643,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,000,000 | $12,972,000 | 0.02% |
| Rock Springs Capital Management LP | 500,000 | $541,000 | 0.01% |